Lactoferrin Market Size
Global Lactoferrin Market reached US$ 450.10 million in 2025 and is projected to witness lucrative growth by reaching up to US$ 913.76 million by 2035. The market is growing at a CAGR of 7.4% during the forecast period 2026-2035. The need for natural and beneficial ingredients in food, beverages, and dietary supplements is rising.
Since lactoferrin is a naturally occurring bioactive protein, it fits with this trend. In order to provide health advantages and satisfy customer desire for natural and useful ingredients, more and more products are being developed that use lactoferrin.
Due to its potential advantages for newborn health, lactoferrin is increasingly being included in infant formula. Manufacturers are using lactoferrin to improve the nutritional profile and offer immunological support as they work to create baby formula products that closely mimic breast milk. Infant formula products that are lactoferrin-fortified are becoming more and more prevalent on the market.
Lactoferrin Market Key Takeaways
- The market is expected to more than double in value between 2025 and 2035, creating opportunities across infant nutrition, nutraceuticals, and functional food manufacturing.
- Infant formula remains the largest commercial application owing to lactoferrin's similarity to bioactive proteins naturally present in human breast milk.
- Asia-Pacific continues to lead global consumption because of its large infant population, increasing disposable income, and growing awareness of premium nutrition.
- Manufacturers are investing in production expansion and purification technologies to improve supply availability and product quality.
- Functional nutrition and immune health products are becoming important revenue contributors beyond traditional infant nutrition.
- Supply limitations and relatively high production costs continue to influence pricing strategies across the value chain.
Lactoferrin Market Scope
| Metrics | Details |
| Market Size (2025) | US$ 450.10 Million |
| Market Size (2035) | US$ 913.76 Million |
| CAGR | 7.4% (2026-2035) |
| Historic Years | 2023-2024 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Segments Covered | Source, Application, End-Use, Region |
| Leading Region | Asia-Pacific |
| Fastest Growing Region | Asia-Pacific |
To Know More Insights - Download Sample
Lactoferrin Market Dynamics
Growing Demand for Infant Formula Driving the Growth of the Lactoferrin Market
Lactoferrin naturally occurs in breast milk and plays a vital role in infant nutrition. It provides numerous benefits to infants, including immune modulation, antimicrobial activities, and intestinal health. According to CDC, early one in five babies receive formula within their first two days of life. As more infants are fed with formula instead of breast milk, there is a need to enhance the nutritional profile of infant formula. Lactoferrin is considered an essential component in the formulation of high-quality infant formula to provide these important health benefits.
Breast milk is the optimal source of nutrition for infants due to its unique composition that promotes healthy growth and development. Lactoferrin is a bioactive protein found in breast milk, and its inclusion in infant formula helps to mimic the composition of breast milk more closely. Manufacturers are incorporating lactoferrin into infant formula to provide a more comprehensive nutritional profile that resembles breast milk.
The Rising Prevalence of Skin Diseases is Driving the Growth of the Lactoferrin Market
Skin disorders are among the most common ailments in the world, and their incidence is rising. Acne affects nearly 50 million Americans each year, according to the American Academy of Dermatology Association, with moderate acne impacting 85 percent of those aged 12 to 24. With acne being one of the most frequent skin problems among teens, the need for lactoferrin in acne treatments is increasing.
According to a study published in the National Library of Medicine, using lactoferrin for 12 weeks reduces inflammatory lesion count by 38.6%, overall lesion count by 23.1%, and acne grade by 20.3% compared to the placebo group. Lactoferrin is so frequently employed in wound healing and dermal immune response decrease by stimulating connective tissue with epidermal cells and repairing the skin.
High Cost of Lactoferrin Can Restrain the Growth of the Lactoferrin Market
The primary natural sources of lactoferrin are bovine milk and human milk. However, compared to the total need for lactoferrin, the supply from these sources is inadequate. Due to the restricted supply, obtaining sufficient amounts of lactoferrin may need specialized sourcing and processing techniques, which might increase the cost of raw materials.
Supplements, functional foods, and baby formula that include lactoferrin may have higher pricing due to the high cost of lactoferrin manufacture. This may make certain goods more expensive for some customers, resulting in a decline in demand and possible market restrictions.
Lactoferrin Market Segmentation Analysis
Segmented by Source (Bovine Milk, Engineered Rice, Porcine Milk, Human Milk, Murine Milk, Others), by Application (Immune Health, Oral Hygiene, Gut Health, Skincare, Others), by End-Use (Functional Foods & Drinks, Dietary Supplements, Infant Formula, Cosmetics, Others), and by Region, Share, Trends, and Forecast to 2035.
Among end-use industries, infant formula represents the leading revenue-generating segment. The segment benefits from extensive research supporting lactoferrin's role in immune function, gastrointestinal health, antimicrobial protection, and neurological development. As premium infant formula manufacturers continue introducing formulations that better resemble breast milk, lactoferrin demand is expected to remain strong throughout the forecast period.
Within application categories, immune health and gut health continue gaining commercial importance as consumers increasingly prioritize preventive healthcare and nutritional supplementation. Meanwhile, skincare applications are expanding due to growing clinical evidence supporting anti-inflammatory and skin repair benefits.
Bovine milk remains the dominant source because of its commercial scalability and established dairy processing infrastructure, although research into alternative production methods continues to advance.
Lactoferrin Market Regional Analysis
Asia-Pacific Lactoferrin Market
Asia-Pacific maintains the largest share of the global lactoferrin market. Strong demand originates from large birth populations in China and India, increasing consumer awareness regarding infant nutrition, and expanding consumption of premium healthcare products.
China remains particularly influential because of relatively lower breastfeeding rates and sustained demand for premium infant formula products. Policy changes supporting larger family sizes have further contributed to demand for infant nutrition products enriched with functional bioactive ingredients.
North America Lactoferrin Market
North America benefits from strong consumer demand for dietary supplements, functional nutrition, and premium healthcare products. Growing awareness regarding immune wellness and increasing adoption of clinically validated nutritional ingredients continue supporting market expansion.
The region also benefits from established nutraceutical manufacturers, advanced dairy processing capabilities, and ongoing investments in functional food innovation.
Europe Lactoferrin Market
Europe remains an important market due to its mature dairy industry, high regulatory standards, and strong emphasis on scientifically validated nutritional ingredients. Regional manufacturers continue investing in advanced purification technologies and premium dairy bioactive production to serve infant nutrition and clinical nutrition markets.
Lactoferrin Market Companies
The major global players include MILEI GmbH, Farbest Brands, Synlait Ltd., Glanbia Plc., Bega Bionutrients, Saputa Dairy Australia Pty Ltd., Forterra Co-Operative Group, Armor Proteins, Hilmar Cheese Company, Inc., Conagen, Inc.
Lactoferrin Market Key Developments
- On April 18, 2026, Fonterra Co-operative Group announced expansion of its lactoferrin production capabilities in New Zealand to meet rising global demand from infant nutrition and immune health supplement manufacturers. The expansion focuses on improving extraction efficiency and scaling high-purity lactoferrin supply for premium nutrition applications across Asia-Pacific and North America.
- On January 30, 2026, FrieslandCampina strengthened its lactoferrin innovation pipeline by advancing next-generation purification technologies aimed at enhancing bioactive protein stability for use in infant formula and clinical nutrition products. The company highlighted increasing demand for immune-supporting ingredients as a key growth driver.
- On October 9, 2025, Glanbia plc expanded its bioactive dairy ingredients portfolio by increasing investment in lactoferrin-based functional nutrition solutions targeting sports nutrition, immunity support, and maternal health segments. The initiative supports rising demand for high-value dairy-derived bioactives in global nutraceutical markets.
- On August 22, 2025, Synlait Milk Ltd entered a strategic supply agreement with infant formula manufacturers to scale lactoferrin-enriched ingredients production. The company emphasized strong growth in demand for human milk–like bioactive proteins and premium infant nutrition formulations.
Why Purchase the Report?
- To visualize the global lactoferrin market segmentation based on source, application, end-use, and region understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous lactoferrin market-level data points all for segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The Global Lactoferrin Market Report Would Provide Approximately 61 Tables, 64 Figures, and 102 Pages.
Target Audience 2026
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
Conclusion
The lactoferrin market presents an attractive long-term growth opportunity driven by expanding demand for premium infant nutrition, clinically supported immune health ingredients, and high-value functional food formulations. Continued investments in production capacity, purification technologies, and strategic supply partnerships are strengthening industry competitiveness while improving product availability. Although manufacturing costs and raw material availability remain important commercial considerations, companies capable of delivering consistent quality, reliable supply, and application-specific innovation are expected to strengthen their market position through 2035. Growing healthcare awareness, premium nutrition trends, and increasing adoption across multiple end-use industries make lactoferrin an important ingredient category for manufacturers, investors, and strategic buyers to monitor over the coming decade.
